CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860202. A total of 13 filers reported holding CLEVELAND BIOLABS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $0 | – | 265 | 0.0% | 0.00% | – |
Q3 2019 | $0 | – | 265 | 0.0% | 0.00% | – |
Q2 2019 | $0 | – | 265 | 0.0% | 0.00% | – |
Q1 2019 | $0 | – | 265 | 0.0% | 0.00% | – |
Q4 2018 | $0 | – | 265 | +1225.0% | 0.00% | – |
Q3 2018 | $0 | – | 20 | 0.0% | 0.00% | – |
Q2 2018 | $0 | – | 20 | 0.0% | 0.00% | – |
Q1 2018 | $0 | – | 20 | 0.0% | 0.00% | – |
Q4 2017 | $0 | -100.0% | 20 | -99.4% | 0.00% | – |
Q3 2017 | $12,000 | -92.5% | 3,570 | -90.8% | 0.00% | -100.0% |
Q2 2017 | $159,000 | +189.1% | 38,680 | 0.0% | 0.00% | +100.0% |
Q1 2017 | $55,000 | -11.3% | 38,680 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $62,000 | -18.4% | 38,680 | -0.4% | 0.00% | 0.0% |
Q3 2016 | $76,000 | -7.3% | 38,843 | +6.0% | 0.00% | 0.0% |
Q2 2016 | $82,000 | -34.9% | 36,643 | -5.7% | 0.00% | -50.0% |
Q1 2016 | $126,000 | -22.7% | 38,843 | -0.1% | 0.00% | -33.3% |
Q4 2015 | $163,000 | +3.2% | 38,888 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $158,000 | +192.6% | 38,888 | +106.4% | 0.00% | +200.0% |
Q2 2015 | $54,000 | -53.4% | 18,843 | -45.1% | 0.00% | -50.0% |
Q1 2015 | $116,000 | – | 34,293 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
THOMPSON DAVIS & CO., INC. | 1,800 | $8,000 | 0.01% |
VANGUARD GROUP INC | 4,644,077 | $162,991,000 | 0.01% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 38,888 | $158,000 | 0.00% |
Winfield Associates, Inc. | 786 | $3,000 | 0.00% |
Virtu KCG Holdings LLC | 11,022 | $48,000 | 0.00% |
UBS Group AG | 182 | $0 | 0.00% |
BLACKROCK ADVISORS LLC | 2,800 | $12,000 | 0.00% |
US BANCORP \DE\ | 100 | $0 | 0.00% |
AMERICAN INTERNATIONAL GROUP, INC. | 37 | $0 | 0.00% |
BANK OF AMERICA CORP /DE/ | 150 | $1,000 | 0.00% |